223 related articles for article (PubMed ID: 17252594)
1. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer.
Patel BP; Shah SV; Shukla SN; Shah PM; Patel PS
Head Neck; 2007 Jun; 29(6):564-72. PubMed ID: 17252594
[TBL] [Abstract][Full Text] [Related]
2. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
5. Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-1N: hamster oral squamous cell carcinoma with high potential lymph node metastasis.
Zhang Y; Wang C; Mizukami H; Itoh H; Kusama M; Ozawa K; Jinbu Y
J Exp Clin Cancer Res; 2006 Sep; 25(3):417-23. PubMed ID: 17167983
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
7. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
Waas ET; Wobbes T; Lomme RM; DeGroot J; Ruers T; Hendriks T
Br J Surg; 2003 Dec; 90(12):1556-64. PubMed ID: 14648736
[TBL] [Abstract][Full Text] [Related]
9. The matrix metalloproteinase system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
11. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
[TBL] [Abstract][Full Text] [Related]
12. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
13. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC
J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371
[TBL] [Abstract][Full Text] [Related]
14. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
15. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
Wu SH; Zhang J; Li Y; Li JM
Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer.
Okada N; Ishida H; Murata N; Hashimoto D; Seyama Y; Kubota S
Biochem Biophys Res Commun; 2001 Oct; 288(1):212-6. PubMed ID: 11594775
[TBL] [Abstract][Full Text] [Related]
17. [The effects of MMPs and TIMPs on the metastasis of oral squamous cell carcinoma to neck lymph nodes].
Liu G; Li J; Li Z; Chen X
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug; 19(4):216-8, 224. PubMed ID: 12539723
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
Sharwani A; Jerjes W; Hopper C; Lewis MP; El-Maaytah M; Khalil HS; Macrobert AJ; Upile T; Salih V
Arch Oral Biol; 2006 Dec; 51(12):1104-11. PubMed ID: 16889746
[TBL] [Abstract][Full Text] [Related]
19. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
Yorioka CW; Coletta RD; Alves F; Nishimoto IN; Kowalski LP; Graner E
Int J Oncol; 2002 Jan; 20(1):189-94. PubMed ID: 11743663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]